Cargando…

Effect of Glycerol on Fosfomycin Activity against Escherichia coli

Fosfomycin is an antimicrobial that inhibits the biosynthesis of peptidoglycan by entering the bacteria through two channels (UhpT and GlpT). Glycerol is clinically used as a treatment for elevated intracranial pressure and induces the expression of glpT in Escherichia coli. Glycerol might offer syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz-Padilla, Miriam, Portillo-Calderón, Inés, Velázquez-Escudero, Ana, Rodríguez-Baño, Jesús, Pascual, Álvaro, Rodríguez-Martínez, José Manuel, Docobo-Pérez, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686493/ https://www.ncbi.nlm.nih.gov/pubmed/36421256 http://dx.doi.org/10.3390/antibiotics11111612

Ejemplares similares

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
por: Martín-Gutiérrez, Guillermo, et al.
Publicado: (2020)

Disbalancing Envelope Stress Responses as a Strategy for Sensitization of Escherichia coli to Antimicrobial Agents
por: Recacha, Esther, et al.
Publicado: (2021)

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli
por: Diaz-Diaz, S, et al.
Publicado: (2021)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli
por: Cattoir, Vincent, et al.
Publicado: (2020)

Resensitization of Fosfomycin-Resistant Escherichia coli Using the CRISPR System
por: Walflor, Haniel Siqueira Mortagua, et al.
Publicado: (2022)

Population Pharmacokinetics of Piperacillin in Non-Critically Ill Patients with Bacteremia Caused by Enterobacteriaceae
por: Merino-Bohórquez, Vicente, et al.
Publicado: (2021)

Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2012)

Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence
por: Morales Barroso, Isabel, et al.
Publicado: (2018)

Prevalence, Incidence, and Risk Factors for Intestinal Colonization Due to Fluoroquinolone-Resistant ST131 Escherichia coli: a Longitudinal Study in Highly Dependent, Long-Term Care Facility Residents
por: Salamanca-Rivera, Elena, et al.
Publicado: (2022)

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates
por: Dzib-Baak, Haziel Eleazar, et al.
Publicado: (2022)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2021)

Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli
por: Machuca, Jesús, et al.
Publicado: (2017)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
por: Benzerara, Yahia, et al.
Publicado: (2017)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2020)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter
por: Hirakawa, Hidetada, et al.
Publicado: (2018)

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
por: Li, Ya, et al.
Publicado: (2015)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2023)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Rewiring of glycerol metabolism in Escherichia coli for effective production of recombinant proteins
por: Chiang, Chung-Jen, et al.
Publicado: (2020)

Deciphering pharmacokinetics and pharmacodynamics of fosfomycin
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2019)

Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013)

Detection of ESBL/AmpC-Producing and Fosfomycin-Resistant Escherichia coli From Different Sources in Poultry Production in Southern Brazil
por: Gazal, Luís Eduardo de Souza, et al.
Publicado: (2021)

Bioconversion of glycerol for bioethanol production using isolated Escherichia coli ss1
por: Suhaimi, Sheril Norliana, et al.
Publicado: (2012)

Biosynthesis of catechol melanin from glycerol employing metabolically engineered Escherichia coli
por: Mejía-Caballero, Alejandra, et al.
Publicado: (2016)

Metabolic engineering of Escherichia coli for production of n-butanol from crude glycerol
por: Saini, Mukesh, et al.
Publicado: (2017)

Production of γ-terpinene by metabolically engineered Escherichia coli using glycerol as feedstock
por: Qi, Chang, et al.
Publicado: (2018)

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
por: Kussmann, Manuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gkck90m7tnor3iggpamf2pi2kk